๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
541 medicines starting with โ€œRโ€
MedicineActive substanceLicence holderStatus
Rivaroxaban Krka 2.5 mg film-coated tablets
PA1347/098/001
Rivaroxaban KRKA, d.d., Novo mesto Not marketed
Rivaroxaban Krka 20 mg film-coated tablets
PA1347/098/004
Rivaroxaban KRKA, d.d., Novo mesto Marketed
Rivaroxaban MSN 10 mg film-coated tablets
PA23250/004/002
Rivaroxaban MSN Labs Europe Limited Not marketed
Rivaroxaban MSN 15 mg film-coated tablets
PA23250/004/003
Rivaroxaban MSN Labs Europe Limited Not marketed
Rivaroxaban MSN 2.5 mg film-coated tablets
PA23250/004/001
Rivaroxaban MSN Labs Europe Limited Not marketed
Rivaroxaban MSN 20 mg film-coated tablets
PA23250/004/004
Rivaroxaban MSN Labs Europe Limited Not marketed
Rivaroxaban Pinewood 10 mg film coated tablets
PA0281/266/001
Rivaroxaban Pinewood Laboratories Limited Not marketed
Rivaroxaban Pinewood 15 mg film-coated tablets
PA0281/266/002
Rivaroxaban Pinewood Laboratories Limited Not marketed
Rivaroxaban Pinewood 20 mg film-coated tablets
PA0281/266/003
Rivaroxaban Pinewood Laboratories Limited Not marketed
Rivaroxaban Rowa 10 mg film-coated tablets
PA0074/097/001
Rivaroxaban Rowa Pharmaceuticals Limited, Not marketed
Rivaroxaban Rowa 15 mg film-coated tablets
PA0074/097/002
Rivaroxaban Rowa Pharmaceuticals Limited, Not marketed
Rivaroxaban Rowa 20 mg film-coated tablets
PA0074/097/003
Rivaroxaban Rowa Pharmaceuticals Limited, Not marketed
Rivaroxaban Rowex 10 mg film-coated tablets
PA0711/275/001
Rivaroxaban Rowex Limited, Marketed
Rivaroxaban Rowex 15 mg film-coated tablets
PA0711/275/002
Rivaroxaban Rowex Limited, Marketed
Rivaroxaban Rowex 20 mg film-coated tablets
PA0711/275/003
Rivaroxaban Rowex Limited, Marketed
Rivaroxaban Teva 10 mg film-coated tablets
PA22579/002/001
Rivaroxaban TEVA GmbH Marketed
Rivaroxaban Teva 15 mg film-coated tablets
PA22579/002/002
Rivaroxaban TEVA GmbH Marketed
Rivaroxaban Teva 20 mg film-coated tablets
PA22579/002/003
Rivaroxaban TEVA GmbH Marketed
Rivaroxaban Tillomed 10 mg film-coated tablets
PA25239/003/002
Rivaroxaban Tillomed Malta Limited Not marketed
Rivaroxaban Tillomed 15 mg film-coated tablets
PA25239/003/003
Rivaroxaban Tillomed Malta Limited Not marketed
Rivaroxaban Tillomed 15 mg film-coated tablets Rivaroxaban Tillomed 20 mg film-coated tablets
PA25239/003/004
Rivaroxaban, Rivaroxaban Tillomed Malta Limited Not marketed
Rivaroxaban Tillomed 2.5 mg film-coated tablets
PA25239/003/001
Rivaroxaban Tillomed Malta Limited Not marketed
Rivaroxaban Tillomed 20 mg film-coated tablets
PA25239/003/005
Rivaroxaban Tillomed Malta Limited Not marketed
Rivaroxaban Viatris 10 mg film-coated tablets
EU/1/21/1588/015-025
Rivaroxaban Viatris Limited โ€”
Rivaroxaban Viatris 15 mg film-coated tablets
EU/1/21/1588/026-040
Rivaroxaban Viatris Limited โ€”
Rivaroxaban Viatris 15 mg film-coated tablets Rivaroxaban Viatris 20 mg film-coated tablets
EU/1/21/1588/055
Rivaroxaban, Rivaroxaban Viatris Limited โ€”
Rivaroxaban Viatris 2.5 mg film-coated tablets
EU/1/21/1588/001-014
Rivaroxaban Viatris Limited โ€”
Rivaroxaban Viatris 20 mg film-coated tablets
EU/1/21/1588/041-054
Rivaroxaban Viatris Limited โ€”
Rivastigmine 1 A Pharma 1.5 mg hard capsules
EU/1/09/585/001-4
Rivastigmine hydrogen tartrate 1 A Pharma GmbH โ€”
Rivastigmine 1 A Pharma 2 mg/ml oral solution
EU/1/09/585/017-018
Rivastigmine hydrogen tartrate 1 A Pharma GmbH โ€”
Rivastigmine 1 A Pharma 3 mg hard capsules
EU/1/09/585/005-8
Rivastigmine hydrogen tartrate 1 A Pharma GmbH โ€”
Rivastigmine 1 A Pharma 4.5 mg hard capsules
EU/1/09/585/009-12
Rivastigmine hydrogen tartrate 1 A Pharma GmbH โ€”
Rivastigmine 1 A Pharma 6 mg hard capsules
EU/1/09/585/013-16
Rivastigmine hydrogen tartrate 1 A Pharma GmbH โ€”
Rivastigmine Actavis 1.5 mg hard capsules
EU/1/11/693/001-004
Rivastigmine hydrogen tartrate Actavis Group hf โ€”
Rivastigmine Actavis 3 mg hard capsules
EU/1/11/693/005-008
Rivastigmine hydrogen tartrate Actavis Group hf โ€”
Rivastigmine Actavis 4.5 mg hard capsules
EU/1/11/693/009-012
Rivastigmine hydrogen tartrate Actavis Group hf โ€”
Rivastigmine Actavis 6 mg hard capsules
EU/1/11/693/013-016
Rivastigmine hydrogen tartrate Actavis Group hf โ€”
Rivastigmine HEXAL 1.5 mg hard capsules
EU/1/09/589/1-4
Rivastigmine hydrogen tartrate Hexal AG โ€”
Rivastigmine HEXAL 2 mg/ml oral solution
EU/1/09/589/017-018
Rivastigmine hydrogen tartrate Hexal AG โ€”
Rivastigmine HEXAL 3 mg hard capsules
EU/1/09/589/5-8
Rivastigmine hydrogen tartrate Hexal AG โ€”
Rivastigmine HEXAL 4.5 mg hard capsules
EU/1/09/589/9-12
Rivastigmine hydrogen tartrate Hexal AG โ€”
Rivastigmine HEXAL 6 mg hard capsules
EU/1/09/589/13-16
Rivastigmine hydrogen tartrate Hexal AG โ€”
Rivastigmine Sandoz 1.5 mg hard capsules
EU/1/09/599/001-003
Rivastigmine hydrogen tartrate Sandoz Pharmaceuticals GmbH โ€”
Rivastigmine Sandoz 2 mg/ml oral solution
EU/1/09/599/017-018
Rivastigmine hydrogen tartrate Sandoz Pharmaceuticals GmbH โ€”
Rivastigmine Sandoz 3 mg hard capsules
EU/1/09/599/005-007
Rivastigmine hydrogen tartrate Sandoz Pharmaceuticals GmbH โ€”
Rivastigmine Sandoz 4.5 mg hard capsules
EU/1/09/599/009-011
Rivastigmine hydrogen tartrate Sandoz Pharmaceuticals GmbH โ€”
Rivastigmine Sandoz 6 mg hard capsules
EU/1/09/599/013-015
Rivastigmine hydrogen tartrate Sandoz Pharmaceuticals GmbH โ€”
Rivotril 0.5 mg Tablets
PA2239/020/001
Clonazepam CHEPLAPHARM Arzneimittel GmbH Marketed
Rixathon 100 mg concentrate for solution for infusion
EU/1/17/1185/001-002
Rituximab Sandoz GmbH โ€”
Rixathon 500 mg concentrate for solution for infusion
EU/1/17/1185/003-004
Rituximab Sandoz GmbH โ€”
โ† 5 6 7 8 9 10 11 โ†’
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.